Clinical Trial Update: Enable I Long-term Follow-up Study

View source ↗

Summary

Medtronic's Enable I long-term follow-up study for aortic valve disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Insufficiency
• Aortic Valve Stenosis

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Aortic Valve Stenosis, Aortic Valve Insufficiency | Status: TERMINATED